Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass

Clinical trial NCT00130871 · COMPLETED

Trial details

NCT number: NCT00130871
Sponsor: Orion Corporation, Orion Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Heart Disease

Start date: 2004-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.